Results
Venus Remedies FY26 Results, ₹10 Dividend, Board Appointments
Venus Remedies approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with unmodified audit opinions.
Board recommended a final dividend of ₹10 (100%) per e
